Cargando…

The Multidrug Resistance-Reversing Activity of a Novel Antimicrobial Peptide

The overexpression of ATP-binding cassette (ABC) transporters is a common cause of multidrug resistance (MDR) in cancers. The intracellular drug concentration of cancer cells can be decreased relative to their normal cell counterparts due to increased expression of ABC transporters acting as efflux...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teng, Qiu-Xu, Luo, Xiaofang, Lei, Zi-Ning, Wang, Jing-Quan, Wurpel, John, Qin, Zuodong, Yang, Dong-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409168/ https://www.ncbi.nlm.nih.gov/pubmed/32707710 http://dx.doi.org/10.3390/cancers12071963

Ejemplares similares

Antimicrobial Peptide Reverses ABCB1-Mediated Chemotherapeutic Drug Resistance
por: Luo, Xiaofang, et al.
Publicado: (2020)

Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an in vitro Study
por: Ji, Ning, et al.
Publicado: (2019)

Overcoming multidrug resistance by knockout of ABCB1 gene using CRISPR/Cas9 system in SW620/Ad300 colorectal cancer cells
por: Lei, Zi‐Ning, et al.
Publicado: (2021)

Reversal of Cancer Multidrug Resistance (MDR) Mediated by ATP-Binding Cassette Transporter G2 (ABCG2) by AZ-628, a RAF Kinase Inhibitor
por: Wang, Jing-Quan, et al.
Publicado: (2020)

Cabozantinib Reverses Topotecan Resistance in Human Non-Small Cell Lung Cancer NCI-H460/TPT10 Cell Line and Tumor Xenograft Model
por: Lei, Zi-Ning, et al.
Publicado: (2021)

Understanding and targeting resistance mechanisms in cancer
por: Lei, Zi‐Ning, et al.
Publicado: (2023)

Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells
por: Zhang, Wei, et al.
Publicado: (2018)

Novel Antimicrobial Peptide “Octoprohibitin” against Multidrug Resistant Acinetobacter baumannii
por: Jayathilaka, E. H. T. Thulshan, et al.
Publicado: (2022)

Establishment and Characterization of a Topotecan Resistant Non-small Cell Lung Cancer NCI-H460/TPT10 Cell Line
por: Lei, Zi-Ning, et al.
Publicado: (2020)

VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters
por: Ji, Ning, et al.
Publicado: (2018)

Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression
por: Liao, Dan, et al.
Publicado: (2019)

Antimicrobial peptides: new hope in the war against multidrug resistance
por: Mwangi, James, et al.
Publicado: (2019)

Targeting Multidrug Resistance With Antimicrobial Peptide-Decorated Nanoparticles and Polymers
por: Maleki Dizaj, Solmaz, et al.
Publicado: (2022)

Efficiency of Antimicrobial Peptides Against Multidrug-Resistant Staphylococcal Pathogens
por: Le, Mi Nguyen-Tra, et al.
Publicado: (2022)

Identification of Novel Vaccine Candidates against Multidrug-Resistant Acinetobacter baumannii
por: Moriel, Danilo G., et al.
Publicado: (2013)

Antibacterial and Antibiofilm Activities of Novel Antimicrobial Peptides against Multidrug-Resistant Enterotoxigenic Escherichia Coli
por: Wu, Kang-Chi, et al.
Publicado: (2021)

Bruton’s Tyrosine Kinase (BTK) Inhibitor RN486 Overcomes ABCB1-Mediated Multidrug Resistance in Cancer Cells
por: Dong, Xing-Duo, et al.
Publicado: (2020)

Insights on the structure–function relationship of human multidrug resistance protein 7 (MRP7/ABCC10) from molecular dynamics simulations and docking studies
por: Wang, Jing‐Quan, et al.
Publicado: (2021)

Antimicrobial Peptide Cec4 Eradicates Multidrug-Resistant Acinetobacter baumannii in vitro and in vivo
por: Peng, Jian, et al.
Publicado: (2023)

The antimicrobial peptide LI14 combats multidrug-resistant bacterial infections
por: Shi, Jingru, et al.
Publicado: (2022)

Antimicrobial, Anticancer and Multidrug-Resistant Reversing Activity of Novel Oxygen-, Sulfur- and Selenoflavones and Bioisosteric Analogues
por: Marć, Małgorzata Anna, et al.
Publicado: (2020)

Development of novel ultrashort antimicrobial peptide nanoparticles with potent antimicrobial and antibiofilm activities against multidrug-resistant bacteria
por: Almaaytah, Ammar, et al.
Publicado: (2017)

Reversal of multidrug resistance by surfactants.
por: Woodcock, D. M., et al.
Publicado: (1992)

The Role of Antimicrobial Peptides in Preventing Multidrug-Resistant Bacterial Infections and Biofilm Formation
por: Park, Seong-Cheol, et al.
Publicado: (2011)

Engineered Cationic Antimicrobial Peptides (eCAPs) to Combat Multidrug-Resistant Bacteria
por: Deslouches, Berthony, et al.
Publicado: (2020)

Antimicrobial and Anti-Biofilm Peptide Octominin for Controlling Multidrug-Resistant Acinetobacter baumannii
por: Jayathilaka, E. H. T. Thulshan, et al.
Publicado: (2021)

Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells
por: Feng, Weiguo, et al.
Publicado: (2020)

Dual TTK/CLK2 inhibitor, CC‐671, selectively antagonizes ABCG2‐mediated multidrug resistance in lung cancer cells
por: Wu, Zhuo‐Xun, et al.
Publicado: (2020)

In Vitro and In Vivo Antimicrobial Activity of the Novel Peptide OMN6 against Multidrug-Resistant Acinetobacter baumannii
por: Michaeli, Janna, et al.
Publicado: (2022)

Tridecaptin-inspired antimicrobial peptides with activity against multidrug-resistant Gram-negative bacteria
por: Ballantine, Ross D., et al.
Publicado: (2019)

Synergy Pattern of Short Cationic Antimicrobial Peptides Against Multidrug-Resistant Pseudomonas aeruginosa
por: Ruden, Serge, et al.
Publicado: (2019)

Multidrug-Resistant Microbial Therapy Using Antimicrobial Peptides and the CRISPR/Cas9 System
por: Getahun, Yared Abate, et al.
Publicado: (2022)

Antimicrobial Activity of an Fmoc-Plantaricin 149 Derivative Peptide against Multidrug-Resistant Bacteria
por: Righetto, Gabriela Marinho, et al.
Publicado: (2023)

Combined Use of Antimicrobial Peptides with Antiseptics against Multidrug-Resistant Bacteria: Pros and Cons
por: Zharkova, Maria S., et al.
Publicado: (2023)

Designing double-site lipidated peptide amphiphiles as potent antimicrobial biomaterials to combat multidrug-resistant bacteria
por: Lai, Zhenheng, et al.
Publicado: (2022)

Research Progress on Natural Diterpenoids in Reversing Multidrug Resistance
por: Deng, Zhuo-fen, et al.
Publicado: (2022)

M3814, a DNA-PK Inhibitor, Modulates ABCG2-Mediated Multidrug Resistance in Lung Cancer Cells
por: Wu, Zhuo-Xun, et al.
Publicado: (2020)

BMS-599626, a Highly Selective Pan-HER Kinase Inhibitor, Antagonizes ABCG2-Mediated Drug Resistance
por: Ashar, Yunali V., et al.
Publicado: (2020)

The race for antimicrobials in the multidrug resistance era
por: Molina‐Santiago, Carlos, et al.
Publicado: (2017)

Hollow MIL-125 Nanoparticles Loading Doxorubicin Prodrug and 3-Methyladenine for Reversal of Tumor Multidrug Resistance
por: Guo, Qingfeng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vr40d04rn0a58o3eh7d4qi7n0c